Firdapse Alternatives Compared
| Firdapse (amifampridine) | Amifampridine | Ruzurgi (amifampridine) |
|
|---|
| Firdapse (amifampridine) | Amifampridine | Ruzurgi (amifampridine) |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Lambert-Eaton Myasthenic Syndrome. Firdapse may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Lambert-Eaton Myasthenic Syndrome. Amifampridine may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Lambert-Eaton Myasthenic Syndrome. Ruzurgi may also be used for purposes not listed in this medication guide. |
||||||||
| More about Firdapse (amifampridine) | More about Amifampridine | More about Ruzurgi (amifampridine) | ||||||||
| Ratings & Reviews | ||||||||||
|
Firdapse has an average rating of 1.0 out of 10 from a total of 3 ratings on Drugs.com. 0% of reviewers reported a positive effect, while 100% reported a negative effect. |
Amifampridine has an average rating of 4.7 out of 10 from a total of 6 ratings on Drugs.com. 33% of reviewers reported a positive effect, while 50% reported a negative effect. |
Ruzurgi has an average rating of 10.0 out of 10 from a total of 2 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
||||||||
| Drug Class | ||||||||||
| Side Effects | ||||||||||
| Generic Availability | ||||||||||
|
N/A |
N/A |
|||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||
View all Firdapse prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
| Dosage Forms Available | ||||||||||
|
N/A |
N/A |
||||||||
| Brand Names | ||||||||||
| Other amifampridine brands include: Ruzurgi | Firdapse, Ruzurgi | Other amifampridine brands include: Firdapse | ||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||
|
2.5 hours |
2.5 hours |
2.5 hours |
||||||||
| CSA Schedule ** View glossary of terms | ||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | ||||||||||
|
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||
| Drug Interactions | ||||||||||
|
A total of 199 drugs are known to interact with Firdapse:
|
A total of 199 drugs are known to interact with Amifampridine:
|
A total of 199 drugs are known to interact with Ruzurgi:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
| Disease Interactions | ||||||||||
| First Approval Date | ||||||||||
|
November 28, 2018 |
November 28, 2018 |
N/A |
||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||
|
N/A |
N/A |
N/A |
||||||||
| More Information | ||||||||||
| Patient resources | ||||||||||
| Professional Resources | ||||||||||
| Related Treatment Guide | ||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.